RxDoctor Payments Data

Johnny Ball, NP

Family Medicine · Smithville, TNNPI 1902532930

Payments from drug & device makers

$1,134in general payments, 2019–2025

Across 66 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$248
  • Lilly USA, LLC$166
  • AstraZeneca$142
  • AbbVie$138
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$112
  • Medtronic$55
  • plus $274 from 9 others

What the payments were for

  • Food & beverage$1,134100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,134 in reported general payments places this provider in the 60th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$39,579
Medicare patients
133
Services billed
1,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban109$98,593
RinvoqUpadacitinib12$75,631
OzempicSemaglutide46$59,788
Breztri AerosphereBudesonide/Glycopyr/Formoterol47$48,643
JardianceEmpagliflozin33$47,894
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$41,360
XareltoRivaroxaban22$27,254
MounjaroTirzepatide24$24,097
KerendiaFinerenone23$20,903
QuliptaAtogepant17$18,599
FarxigaDapagliflozin Propanediol18$15,731
Combivent RespimatIpratropium/Albuterol Sulfate16$12,090
JanuviaSitagliptin Phosphate12$10,635
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$6,899
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen175$3,764

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Qulipta$138$94,23029 claims
AstraZenecaBreztri Aerosphere, Farxiga$142$64,37365 claims
Novo NordiskOzempic$248$59,78846 claims
Lilly USA, LLCMounjaro$166$24,09724 claims
BayerKerendia$33$20,90323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Smithville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →